A detailed history of Elefante Mark B transactions in Stryker Corp stock. As of the latest transaction made, Elefante Mark B holds 855 shares of SYK stock, worth $307,911. This represents 0.2% of its overall portfolio holdings.

Number of Shares
855
Previous 890 3.93%
Holding current value
$307,911
Previous $352 Million 10.24%
% of portfolio
0.2%
Previous 0.26%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

SELL
$368.57 - $403.53 $12,899 - $14,123
-35 Reduced 3.93%
855 $316 Million
Q2 2025

Jul 25, 2025

SELL
$337.37 - $395.63 $6,747 - $7,912
-20 Reduced 2.2%
890 $352 Million
Q1 2025

May 06, 2025

SELL
$355.18 - $399.9 $8,879 - $9,997
-25 Reduced 2.67%
910 $339 Million
Q4 2024

Feb 13, 2025

SELL
$345.14 - $392.15 $100,090 - $113,723
-290 Reduced 23.67%
935 $337 Million
Q1 2020

May 07, 2020

BUY
$126.5 - $225.1 $154,962 - $275,747
1,225 New
1,225 $203,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $136B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Elefante Mark B Portfolio

Follow Elefante Mark B and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elefante Mark B, based on Form 13F filings with the SEC.

News

Stay updated on Elefante Mark B with notifications on news.